Ameriprise’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Ameriprise’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-69,000	Closed	-$1.68M	–	3776
2017 Q4	$1.68M	Buy	+69,000	New	+$1.33M	﹤0.01%	2742
2017 Q1	–	Sell	-55,780	Closed	-$1.06M	–	3768
2016 Q4	$1.06M	Sell	55,780 -3,240	-5%	-$62.2K	﹤0.01%	2952
2016 Q3	$1.31M	Sell	59,020 -16,028	-21%	-$301K	﹤0.01%	2796
2016 Q2	$1.37M	Buy	75,048 +1,612	+2%	+$27.8K	﹤0.01%	2734
2016 Q1	$1.34M	Sell	73,436 -67,489	-48%	-$1.09M	﹤0.01%	2724
2015 Q4	$2.38M	Buy	140,925 +87,825	+165%	+$1.49M	﹤0.01%	2502
2015 Q3	$957K	Buy	53,100 +27,300	+106%	+$608K	﹤0.01%	2994
2015 Q2	$667K	Hold	25,800	–	–	﹤0.01%	3317
2015 Q1	$565K	Buy	+25,800	New	+$557K	﹤0.01%	3156

Ameriprise's ENTL Position: Q1 2018 in Review

Ameriprise sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 69,000 shares — an estimated $1.68M sold.

Ameriprise first reported a position in ENTL in Q1 2015 and held it in 9 quarters. The position peaked at $2.38M in Q4 2015. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Ameriprise reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Ameriprise sold 69,000 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.68M.
Ameriprise first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
Ameriprise's Entellus Medical, Inc. Common Stock position peaked at $2.38M in Q4 2015.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Ameriprise's 13F filing for Q1 2018, filed 15 May 2018.